These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 711498)

  • 21. Center for Disease Control (CDC) flow cytometry panel for human immunodeficiency virus infection allows recognition of infectious mononucleosis caused by Epstein-Barr virus or cytomegalovirus.
    Zidovec Lepej S; Vince A; Rakusic S; Dakovic Rode O; Sonicki Z; Jeren T
    Croat Med J; 2003 Dec; 44(6):702-6. PubMed ID: 14652882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis.
    Crawford DH; Macsween KF; Higgins CD; Thomas R; McAulay K; Williams H; Harrison N; Reid S; Conacher M; Douglas J; Swerdlow AJ
    Clin Infect Dis; 2006 Aug; 43(3):276-82. PubMed ID: 16804839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematologic differences in heterophile-positive and heterophile-negative infectious mononucleosis.
    Ventura KC; Hudnall SD
    Am J Hematol; 2004 Aug; 76(4):315-8. PubMed ID: 15282662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance of infectious mononucleosis cases by use of existing data from state laboratories.
    Caldwell GG; Heath CW
    Public Health Rep; 1982; 97(6):579-82. PubMed ID: 7146308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onset of alopecia areata after Epstein-Barr virus infectious mononucleosis.
    Rodriguez TA; Duvic M;
    J Am Acad Dermatol; 2008 Jul; 59(1):137-9. PubMed ID: 18329131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus and heterophile antibodies in infectious mononucleosis.
    Gotlieb-Stematsky T; Vonsover A; Modan M
    Isr J Med Sci; 1974 Jul; 10(7):731-7. PubMed ID: 4368690
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of BCG vaccination in prevention of cancer.
    Comstock GW; Martinez I; Livesay VT
    J Natl Cancer Inst; 1975 Apr; 54(4):835-9. PubMed ID: 1173247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute infectious mononucleosis and coincidental measles virus infection.
    Atrasheuskaya AV; Kameneva SN; Neverov AA; Ignatyev GM
    J Clin Virol; 2004 Oct; 31(2):160-4. PubMed ID: 15364274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiological analysis of infectious mononucleosis as primary Epstein-Barr virus infection].
    Yamamoto T; Yoshida K; Torasawa K; Tada H; Nakamura Y
    Rinsho Byori; 1992 Nov; 40(11):1210-6. PubMed ID: 1339163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Infectious mononucleosis: study on hospitalized children].
    Carbonero Celis MJ; Torronteras Santiago R; Cintado Bueno C
    An Esp Pediatr; 1999 Dec; 51(6):664-6. PubMed ID: 10666901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus infectious mononucleosis in children. I. Clinical and general laboratory findings.
    Sumaya CV; Ench Y
    Pediatrics; 1985 Jun; 75(6):1003-10. PubMed ID: 2987784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma.
    Hjalgrim H; Smedby KE; Rostgaard K; Molin D; Hamilton-Dutoit S; Chang ET; Ralfkiaer E; Sundström C; Adami HO; Glimelius B; Melbye M
    Cancer Res; 2007 Mar; 67(5):2382-8. PubMed ID: 17332371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series.
    Fark AR
    J Fam Pract; 1991 Feb; 32(2):202, 205-6, 209. PubMed ID: 1846641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Assessment of effectiveness of BCG vaccination against childhood tuberculosis].
    Takamatsu I; Kameda M; Inoue T; Toyoshima K
    Kekkaku; 1995 Sep; 70(9):561-6. PubMed ID: 8523863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TB infection: an exploratory study of BCG protective properties and the possible role of environmental mycobacteria.
    Chihota VN; Nyazema NZ; Mashingaidze S; Mutandiro B
    Cent Afr J Med; 1998 Jun; 44(6):145-8. PubMed ID: 9810394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the incidence of infectious mononucleosis and the presence of Epstein-Barr virus antibodies in the cases of pediatric general medicine service].
    Zappulla F; Re MC; Mazzanti L; Zanelli MG; Sandri S; Baldassarri B; Alonge C; Ragni I; Parisini O; Lucchi A
    Minerva Pediatr; 1984 Oct; 36(19):923-6. PubMed ID: 6099462
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective effect of Bacillus Calmette Guerin (BCG) vaccination in prevention of pulmonary tuberculosis.
    Zodpey SP; Maldhure BR; Kulkarni SW
    J Commun Dis; 2004 Sep; 36(3):159-65. PubMed ID: 16509251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis].
    Imai S
    Hokkaido Igaku Zasshi; 1990 Sep; 65(5):481-92. PubMed ID: 2172132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of literature on infectious mononucleosis with special emphasis on the possible relationship between infectious mononucleosis and infectious hepatitis.
    Gordon L
    J Am Coll Health Assoc; 1970 Jun; 18(5):375-80. PubMed ID: 4315868
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease].
    Sauerbrei A; Sprössig M; Wutzler P; Färber I; Schweizer H; Swoboda R; Wilke J
    Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):170-4. PubMed ID: 6191167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.